Retina · 2014 · 73 citations · 19 references
Health ProfessionsEndocrinologyOphthalmologyDiabetologyOcular DiseaseOcular ImagingDiabetic RetinopathyMacular DiseaseMacular DisordersOphthalmic ImagingOptical Coherence TomographyRetinal ExaminationDiabetic Macular Edema ImagingDiabetic Retinopathy AssessmentDiabetic Retinopathy DetectionMacular Edema AssessmentMatched Control GroupOphthalmologic FindingsOptical Coherence Tomography FindingsSpectral-domain Optical Coherence Tomography
In Brief Purpose: To analyze the presence of hyperreflective foci in Type 1 and Type 2 diabetic patients, separately, without clinically significant diabetic macular edema and visual impairment. Methods: Noninvasive, observational prospective study. Seventeen and 19 consecutive Type 1 and Type 2 diabetic patients (33 and 38 eyes), respectively, were recruited. All patients had no clinically significant diabetic macular edema or visual impairment. Two age- and sex-matched control groups were also included. Patients underwent an ophthalmologic examination including spectral domain optical coherence tomography. Hyperreflective foci were counted considering horizontal B-scan passing through the fovea. Results: On spectral domain optical coherence tomography, patients affected by Type 1 and Type 2 diabetes had a mean of 7.5 ± 4.6 and 9.9 ± 4.5 hyperreflective foci, respectively. Subjects of control groups had a mean of 0.9 ± 0.8 and 1.7 ± 1.5 hyperreflective foci, respectively. Hyperreflective foci amount was statistically different between Type 1 and Type 2 diabetic groups (P = 0.032) and significantly higher in diabetic patients than in controls (P < 0.001). Hyperreflective foci amount was significantly higher in diabetic patients with a poor quality glycometabolic control (P < 0.001 and P = 0.016) or affected by hypertension (P = 0.008). Conclusion: We reported the presence of hyperreflective foci in diabetic patients without diabetic macular edema and visual impairment. This spectral domain optical coherence tomography finding might be a useful marker for the diagnosis and the follow-up in the early stage of diabetic retinopathy. This prospective study was conducted to analyze the presence of hyperreflective foci in diabetic patients without clinically significant diabetic macular edema and visual impairment. This novel spectral domain optical coherence tomography finding might be a useful marker in the early stages of diabetic retinopathy.
19
A central role for inflammation in the pathogenesis of diabetic retinopathy
Antonia M. Joussen, Vassiliki Poulaki, Minh Ly Le et al. · The FASEB Journal · 2004 · 1.2K citations
Medicine, Immunology, Ophthalmology +17
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV
Ronald Klein, Barbara E.K. Klein, Scot E. Moss et al. · Ophthalmology · 1995 · 684 citations